Pharmacists propose class action lawsuit against Shoppers Drug Mart over “risk of causing patient harm”

Previous and current franchise owners proposed a class action lawsuit against Shoppers Drug Mart for “risks to patient safety” and “risk of causing patient harm.”

Pharmacists propose class action lawsuit against Shoppers Drug Mart over “risk of causing patient harm”

The uncertified lawsuit was filed on April 11 at the Ontario Superior Court of Justice by Toronto-based law firm Ricketts Harris LLP.

The franchise owners claim they were placed in situations that caused an “irredeemable conflict of interest” after the company Loblaws acquired Shoppers Drug Mart in 2014. 

Loblaws allegedly created “risks to patient safety and pose a significant risk of causing patient harm,” according to a statement of claim

The practices named in the suit include medication reviews, along with vaccinations, illness diagnoses, and prescriptions. 

Pharmacist terminated for speaking out 

The claim additionally states that Shoppers Drug Mart has terminated contracts with pharmacists who questioned the alleged unsafe practices and “breached key obligations.” 

Sivajana Sivapalan, a pharmacist leading the lawsuit, said he was terminated without reason from Shoppers Drug Mart in 2023 after expressing concerns in regards to their business decisions. 

Sivapalan has been running their pharmacy for 12 years, working in Beamsville, Ontario, since 2011. 

Franchise owners say that despite communicating concern, Loblaws has taken “little to no action” to address the issues.

The Ontario College of Pharmacists

After a meeting with the Ontario College of Pharmacists (OCP) on March 25, they announced a “zero tolerance” for business practices that will prevent the “ability to deliver effective care” to patients. 

The OCP claimed to hear from “thousands” of pharmacists concerning unsafe practices involving patients and stated in a news release they found “inappropriate pressure” to conduct medication reviews “deeply troubling.”

“The College will consider every tool available to us to address those concerns,” they added.

Loblaws has spoken out regarding the proposed suit, saying the case has “no merit whatsoever” and the company will “vigorously defend” itself.

Share this story

Donate now to keep us on the front lines:

Help Keep your News Free

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

“It’s like a bad renter that’s burning the furniture on the way out.” Danielle Smith says Justin Trudeau is actively destroying Canada before he loses the next election.

Mike Campbell

November 4, 2024

Trending News

Keean Bexte

November 2, 2024

Trending News

In his statement, Poilievre said that Trudeau won’t release the names, “Because Trudeau is doing what he always does: he is lying.” 

Walid Tamtam

October 17, 2024

Trending News

New study challenges climate alarmists. “Our results show limited evidence for a warming surge.”

Mike Campbell

October 16, 2024

Trending News

The development comes two days after it was reported that Trudeau is facing an internal Liberal revolt. Trudeau says now is not the time to focus on that.

Walid Tamtam

October 15, 2024

Trending News

OPINION: Health Minister Mark Holland could be reducing the number of smokers nationwide by informing them about the far less harmful, tobacco-less nicotine pouches. Instead, he’s hell-bent on banishing these products and pretending they don’t exist.

Keean Bexte

October 15, 2024

Want to join the conversation?

Sign up now to be able to like, comment and reply to other members. A full membership to our site includes:

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.